Unintended pregnancy during radiotherapy for cancer

Nat Clin Pract Oncol. 2009 Mar;6(3):175-8. doi: 10.1038/ncponc1320. Epub 2009 Jan 27.

Abstract

Background: A 27-year-old woman with upper mediastinum stage IIA Hodgkin lymphoma was treated with six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy. Two months later she received a total of 4,250 cGy to the upper mediastinum and left clavicular region over a 1-month period. One week after completion of radiotherapy she was found to be 13-weeks pregnant. Her physician advised her to terminate pregnancy. She contacted a teratology information service for further information regarding the risks of radiation exposure for her fetus.

Investigations: Estimation of fetal radiation exposure, literature review and synthesis of published cases and effects of fetal radiation exposure.

Diagnosis: Estimated fetal radiation dose between 5 and 18 cGy.

Management: Counseling on the possible risks to the fetus as a result of radiation exposure.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemotherapy, Adjuvant
  • Counseling
  • Female
  • Fetus
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / pathology
  • Hodgkin Disease / radiotherapy*
  • Humans
  • Mediastinal Neoplasms / drug therapy
  • Mediastinal Neoplasms / pathology
  • Mediastinal Neoplasms / radiotherapy*
  • Pregnancy
  • Pregnancy Complications, Neoplastic / drug therapy
  • Pregnancy Complications, Neoplastic / pathology
  • Pregnancy Complications, Neoplastic / radiotherapy*
  • Pregnancy Outcome
  • Pregnancy Trimester, First
  • Pregnancy, Unplanned* / radiation effects
  • Prenatal Exposure Delayed Effects*
  • Radiation Dosage
  • Radiotherapy, Adjuvant / adverse effects
  • Risk Assessment